News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
BioProgress plc - Preliminary Results
April 19, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
London, UK, 19 April 2007: BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the specialty pharmaceutical and healthcare company, is pleased to announce its preliminary results for the year ended 31 December, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Biotech Contraction Continues as Absci, Fate, Oric Downsize
August 13, 2025
·
185 min read
·
BioSpace Editorial Staff
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
August 12, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Dewpoint Slashes Headcount by 70% as Cash Runway Runs Out
August 8, 2025
·
2 min read
·
Tristan Manalac
Earnings
Gilead Confident in PrEP Franchise Even Amid Preventive Task Force Uncertainties
August 8, 2025
·
2 min read
·
Tristan Manalac
